Back to results
US 12,479,807 B2Granted
Methods using HDAC11 inhibitors
AssigneeValo Health, Inc.
InventorsJennifer Lee, Nicholas Barczak, Jaime A. Escobedo, Chiara Conti, Bingsong Han, David R. Lancia, Jr., Cuixian Liu, Matthew W. Martin, Pui Yee Ng, Aleksandra Rudnitskaya, Jennifer R. Thomason, Xiaozhang Zheng
Life of this patent
Estimating the term…
Abstract
The present invention provides methods and uses of inhibitors of histone deacetylase 11 (HDAC11) in the treatment of diseases and/or disorders, such as, for example, cell proliferative diseases.
Claims2
A compound of the following formula:
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.